Brief: Freeline Therapeutics Says Positive Initial Clinical Data From B-Lieve Dose-Confirmation Trial For Flt180a In Hemophilia B Presented At ISTH Congress
10/07/2022 09:23
July 10 (Reuters) - Freeline Therapeutics Holdings PLC
FRLN.O :
* POSITIVE INITIAL CLINICAL DATA FROM B-LIEVE
DOSE-CONFIRMATION
TRIAL FOR FLT180A IN HEMOPHILIA B PRESENTED AT INTERNATIONAL
SOCIETY ON THROMBOSIS AND HAEMOSTASIS CONGRESS
* TREATMENT WAS WELLTOLERATED WITH A GOOD SAFETY PROFILE
Source text for Eikon: ID:nGNX7dYJsh
Further company coverage: FRLN.O
((Reuters.Briefs@thomsonreuters.com;))